M. D. Değer Et Al. , "Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial," JOURNAL OF UROLOGICAL SURGERY , vol.10, no.1, pp.36-42, 2023
Değer, M. D. Et Al. 2023. Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial. JOURNAL OF UROLOGICAL SURGERY , vol.10, no.1 , 36-42.
Değer, M. D., Yıldız, H. A., İncir, C., Özer, M. S., Sarıkaya, A. E., Ergör, G., ... Tunçok, Y.(2023). Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial. JOURNAL OF UROLOGICAL SURGERY , vol.10, no.1, 36-42.
Değer, MÜSLİM Et Al. "Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial," JOURNAL OF UROLOGICAL SURGERY , vol.10, no.1, 36-42, 2023
Değer, MÜSLİM D. Et Al. "Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial." JOURNAL OF UROLOGICAL SURGERY , vol.10, no.1, pp.36-42, 2023
Değer, M. D. Et Al. (2023) . "Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial." JOURNAL OF UROLOGICAL SURGERY , vol.10, no.1, pp.36-42.
@article{article, author={MÜSLİM DOĞAN DEĞER Et Al. }, title={Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial}, journal={JOURNAL OF UROLOGICAL SURGERY}, year=2023, pages={36-42} }